Subcutaneous Daratumumab with Rapid Corticosteroid Tapering in Relapsed or Refractory Multiple Myeloma Patients: Part 3 Update of the Open-Label, Multicenter, Phase 1b Pavo Study

被引:1
|
作者
Nahi, Hareth [1 ]
Usmani, Saad Z. [2 ]
Mateos, Maria-Victoria [3 ]
van de Donk, Niels W. C. J. [4 ]
Moreau, Philippe [5 ]
Oriol, Albert [6 ]
Plesner, Torben [7 ,8 ]
Bandyopadhyay, Nibedita [9 ]
Hellemans, Peter [10 ]
Tromp, Brenda [11 ]
Nnane, Ivo [9 ]
Zemlickis, Donna [12 ]
Farnsworth, Andrew [13 ]
Chari, Ajai [14 ]
机构
[1] Karolinska Univ Hosp Huddinge, Karolinska Inst, Huddinge, Sweden
[2] Levine Canc Inst, Charlotte, NC USA
[3] Univ Hosp Salamanca, IBSAL, Canc Res Ctr IBMCC USAL, Salamanca, Spain
[4] Vrije Univ Amsterdam, Amsterdam UMC, Dept Hematol, Amsterdam, Netherlands
[5] Univ Hosp Hotel Dieu, Hematol, Nantes, France
[6] Hosp Germans Trias Pujol, Inst Catala Oncol & Inst Josep Carreras, Barcelona, Spain
[7] Vejle Hosp, Vejle, Denmark
[8] Univ Southern Denmark, Vejle, Denmark
[9] Janssen Res Dev LLC, Raritan, NJ USA
[10] Janssen Res Dev, Beerse, Belgium
[11] Janssen Res Dev, Leiden, Netherlands
[12] Janssen Res Dev LLC, Toronto, ON, Canada
[13] Janssen Res Dev LLC, High Wycombe, Bucks, England
[14] Tisch Canc Inst, Mt Sinai Sch Med, New York, NY USA
关键词
D O I
10.1182/blood-2021-148990
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1667
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study
    Nahi, Hareth
    Usmani, Saad Z.
    Mateos, Maria-Victoria
    van de Donk, Niels W. C. J.
    Oriol, Albert
    Plesner, Torben
    Bandyopadhyay, Nibedita
    Hellemans, Peter
    Tromp, Brenda
    Nnane, Ivo
    Zemlickis, Donna
    Chari, Ajai
    Moreau, Philippe
    LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 468 - 472
  • [2] Subcutaneous Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma: Part 2 Safety and Efficacy Update of the Open-Label, Multicenter, Phase 1b Study (PAVO)
    Chari, Ajai
    Mateos, Maria-Victoria
    van de Donk, Niels W. C. J.
    Kaufman, Jonathan L.
    Moreau, Philippe
    Oriol, Albert
    Plesner, Torben
    Benboubker, Lotfi
    Nahi, Hareth
    Tang, Jie
    Hellemans, Peter
    Tromp, Brenda
    Clemens, Pamela L.
    Farnsworth, Andrew
    San-Miguel, Jesus F.
    Usmani, Saad Z.
    BLOOD, 2018, 132
  • [3] Subcutaneous daratumumab (DARA) in patients (Pts) with relapsed or refractory multiple myeloma (RRMM): Part 2 update of the open-label, multicenter, dose escalation phase 1b study (PAVO).
    Chari, Ajai
    Usmani, Saad Zafar
    Mateos, Maria-Victoria
    Van De Donk, Niels
    Kaufman, Jonathan L.
    Moreau, Philippe
    Rocafiguera, Albert Oriol
    Plesner, Torben
    Benboubker, Lotfi
    Liu, Kevin
    Hellemans, Peter
    Masterson, Tara J.
    Clemens, Pamela L.
    Farnsworth, Andrew
    Nahi, Hareth
    San-Miguel, Jesus
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] SUBCUTANEOUS DARATUMUMAB IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): AN OPEN-LABEL, MULTICENTER, DOSE ESCALATION PHASE 1B STUDY (PAVO)
    Mateos, M., V
    Chari, A.
    Nah, H.
    Lokhorst, H.
    Kaufman, J. L.
    Moreau, P.
    Oriol, A.
    Plesner, T.
    Benboubker, L.
    Hellemans, P.
    Masterson, T.
    Clemens, P. L.
    Liu, K.
    San-Miguel, J.
    Usmani, S. Z.
    HAEMATOLOGICA, 2018, 103 : 32 - 33
  • [5] Open-Label, Multicenter, Dose Escalation Phase 1b Study to Assess the Subcutaneous Delivery of Daratumumab in Patients (pts) with Relapsed or Refractory Multiple Myeloma (PAVO)
    Usmani, Saad Z.
    Nahi, Hareth
    Mateos, Maria-Victoria
    Lokhorst, Henk M.
    Chari, Ajai
    Kaufman, Jonathan L.
    Moreau, Philippe
    Oriol, Albert
    Plesner, Torben
    Benboubker, Lotfi
    Hellemans, Peter
    Masterson, Tara
    Clemens, Pamela L.
    Ahmadi, Tahamtan
    Liu, Kevin
    San-Miguel, Jesus
    BLOOD, 2016, 128 (22)
  • [6] Subcutaneous Delivery of Daratumumab in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM): Pavo, an Open-Label, Multicenter, Dose Escalation Phase 1b Study
    Chari, Ajai
    Nahi, Hareth
    Mateos, Maria-Victoria
    Lokhorst, Henk M.
    Kaufman, Jonathan L.
    Moreau, Philippe
    Oriol, Albert
    Plesner, Torben
    Benboubker, Lotfi
    Hellemans, Peter
    Masterson, Tara
    Clemens, Pamela L.
    Liu, Kevin
    San-Miguel, Jesus F.
    Usmani, Saad Z.
    BLOOD, 2017, 130
  • [7] Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma part 2 of the open-label, multicenter, dose-escalation phase Ib study (PAVO)
    San-Miguel, Jesus
    Usmani, Saad Z.
    Mateos, Maria-Victoria
    van de Donk, Niels W. C. J.
    Kaufman, Jonathan L.
    Moreau, Philippe
    Oriol, Albert
    Plesner, Torben
    Benboubker, Lotfi
    Liu, Kevin
    Hellemans, Peter
    Masterson, Tara
    Clemens, Pamela L.
    Luo, Man
    Farnsworth, Andrew
    Nahi, Hareth
    Chari, Ajai
    HAEMATOLOGICA, 2021, 106 (06) : 1725 - 1732
  • [8] Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study.
    Nahi, Hareth
    Usmani, Saad Zafar
    Mateos, Maria-Victoria
    van de Donk, Niels W. C. J.
    Moreau, Philippe
    Oriol, Albert
    Plesner, Torben
    Yang, Shiyi
    Hellemans, Peter
    Tromp, Brenda J.
    Luo, Man
    Zemlickis, Donna
    Farnsworth, Andrew
    Chari, Ajai
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Pharmacokinetics (PK) of Subcutaneous Daratumumab in Patients with Relapsed or Refractory (RR) Multiple Myeloma (MM): Primary Clinical Pharmacology Analysis of the Open-Label, Multicenter, Phase 1b Study (PAVO)
    Clemens, Pamela L.
    Xu, Steven
    Luo, Melody
    Chari, Ajai
    Usmani, Saad Z.
    Mateos, Maria-Victoria
    van de Donk, Niels W. C. J.
    Kaufman, Jonathan L.
    Moreau, Philippe
    Oriol, Albert
    Plesner, Torben
    Benboubker, Lotfi
    San-Miguel, Jesus F.
    Sun, X. Yu-Nien
    Farnsworth, Andrew
    Masterson, Tara
    Hellemans, Peter
    Qi, Ming
    Nahi, Hareth
    BLOOD, 2018, 132
  • [10] Subcutaneous daratumumab in Chinese patients with relapsed or refractory multiple myeloma: an open-label, multicenter, phase 1 study (MMY1010)
    An, Gang
    Ge, Zheng
    Jing, Hongmei
    Liu, Jing
    Yang, Guoping
    Feng, Ru
    Xu, Zhongyuan
    Qi, Ming
    Wang, Jianping
    Song, Juanjuan
    Zhou, Wei
    Sun, Binbin
    Zhu, Dian
    Chen, Xi
    Cui, Canchan
    Qiu, Lugui
    BLOOD SCIENCE, 2024, 6 (03): : e00193